| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.088 | 0.07 |